文献速递主动脉疾病

非破裂腹主动脉瘤开放手术与腔内修复后再干预率比较

Reintervention Rate after Open Surgery and Endovascular Repair for Nonruptured Abdominal Aortic Aneurysms.
PubMed 文献 · Ann Vasc Surg · 2017-05-03

单中心回顾性研究纳入2006年至2016年240例非破裂腹主动脉瘤患者,分为开放修复组146例、符合IFU的EVAR组42例和不符合IFU的EVAR组52例。不符合IFU的EVAR组最终内漏更多(17% vs. 0%,P=0.004),1年和3年免于再干预生存率更低(89%和87% vs. 开放组97%和95%,P=0.043),总生存率三组无显著差异(P=0.098)。

要点

  • 不符合IFU的EVAR组最终内漏发生率显著高于符合IFU组(17% vs. 0%,P=0.004)。
  • 不符合IFU的EVAR组1年和3年免于再干预生存率低于开放组(P=0.043)。
  • 不符合IFU的EVAR需谨慎规划,符合IFU的EVAR与开放组再干预率无显著差异。

核心结论

  • 不符合IFU的EVAR组中期免于再干预生存率和总生存率低于开放组。
  • 不符合IFU的EVAR组最终内漏更常见,再干预更频繁。
  • 在不符合IFU的情况下实施EVAR应谨慎规划。

研究设计与样本

  • 单中心回顾性研究,纳入2006年1月至2016年3月240例非破裂腹主动脉瘤患者。
  • 排除破裂腹主动脉瘤及孤立性髂动脉瘤(伴或不伴直径<5 cm的小腹主动脉瘤)。
  • 分为开放修复组(n=146)、符合IFU的EVAR组(n=42)和不符合IFU的EVAR组(n=52)。

主要发现

  • 开放组院内死亡2例(再灌注损伤或胰腺炎),EVAR组无院内死亡。
  • 不符合IFU的EVAR组最终内漏发生率17%,符合IFU组为0%(P=0.004)。
  • 开放组、符合IFU的EVAR组和不符合IFU的EVAR组平均随访时间分别为42.1、25.3和25.0个月。
  • 1年和3年免于再干预生存率:开放组97%和95%,符合IFU的EVAR组100%和96%,不符合IFU的EVAR组89%和87%(P=0.043)。
  • 1年和3年总生存率:开放组94%和78%,符合IFU的EVAR组90%和86%,不符合IFU的EVAR组93%和56%(P=0.098)。

关键数值与推荐

  • 再干预定义为初始手术后住院期间或之后因移植物相关或剖腹手术相关的再次手术。
  • EVAR后最终内漏定义为各种操作消除内漏后离开手术室前持续存在的I型或III型内漏。
  • 符合IFU的EVAR组与开放组免于再干预生存率无显著差异(P=0.881)。
  • 符合IFU的EVAR组与开放组总生存率无显著差异(P=0.890)。

临床怎么用

  • 对于非破裂腹主动脉瘤,符合IFU的EVAR与开放修复的中期再干预率相当。
  • 不符合IFU的EVAR需谨慎选择,因其内漏和再干预风险更高。
  • 术后随访应关注内漏及再干预,尤其是不符合IFU的EVAR患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We aim to determine the reintervention rate after open aortic aneurysm repair (OAR) or endovascular aneurysm repair (EVAR) according to compliance or noncompliance with the instructions for use (IFU) for commercial endovascular stent grafts. METHODS: After exclusion of those with a ruptured abdominal aortic aneurysm (AAA) and isolated iliac artery aneurysm with or without a small AAA (diameter < 5 cm), 240 patients received OAR or EVAR for a nonruptured AAA between January 2006 and March 2016. EVAR was performed from October 2009. Patients were divided into 3 groups: OAR (n = 146), IFU EVAR (n = 42), and non-IFU EVAR (n = 52). Reintervention was defined as graft-related or laparotomy-related (with an abdominal incision after initial laparotomy) reoperations either during the index admission period or later. Final endoleak after EVAR was defined as persistent type I or III endoleak before exiting operating room after various procedures to eliminate the endoleak. RESULTS: There were 2 in-hospital deaths in the OAR group caused by reperfusion injury or pancreatitis. There was no in-hospital mortality in the EVAR group. Final endoleak was more common in non-IFU EVAR compared with IFU EVAR (17% vs. 0%; P = 0.004). The mean follow-up duration was 42.1 months, 25.3 months, and 25.0 months in the OAR, IFU EVAR, and non-IFU EVAR groups, respectively. Respective reintervention-free survival (RFS) rates at 1 and 3 years differed significantly by group: 97% and 95% in the OAR group, 100% and 96% in the IFU EVAR group, and 89% and 87% for non-IFU EVAR group (P = 0.043) with a higher reintervention rate in the non-IFU EVAR than in the OAR group. There was no significant difference in RFS rate between the OAR and IFU EVAR groups (P = 0.881). Overall survival (OS) rates at 1 and 3 years, respectively, were 94% and 78% in the OAR group, 90% and 86% in the IFU EVAR group, and 93% and 56% in the non-IFU EVAR group (P = 0.098). There were no significant differences between the OAR and IFU EVAR groups (P = 0.890). CONCLUSIONS: In contrast to IFU EVAR group, the RFS and OS rates of non-IFU EVAR group were lower than in the OAR group during mid-term follow-up. Final endoleak was more frequent, and reintervention was more commonly performed in the non-IFU group than in the IFU group. Therefore, performing EVAR in non-IFU situations should be planned carefully.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hwang D, Park S, Kim HK, et al. Reintervention Rate after Open Surgery and Endovascular Repair for Nonruptured Abdominal Aortic Aneurysms. Ann Vasc Surg. 2017. PMID: 28478164. doi:10.1016/j.avsg.2017.03.168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。